Stock | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
---|---|---|---|---|---|---|---|
Aprea Therapeutics, Inc. | Director | Common Stock | 234K | $1.07M | $4.58 | Oct 18, 2024 | Direct |
Aprea Therapeutics, Inc. | Director | Common Stock | 602 | $2.36K | $3.92 | Oct 18, 2024 | By Spouse |
Aprea Therapeutics, Inc. | Director | Stock Options (Right to Buy) | 4.19K | Jun 20, 2024 | Direct |
Symbol | Company | Period | Transactions | Value $ | Form Type | Date Filed | Role |
---|---|---|---|---|---|---|---|
APRE | Aprea Therapeutics, Inc. | Oct 18, 2024 | 1 | -$29.6K | 4 | Oct 25, 2024 | Director |
APRE | Aprea Therapeutics, Inc. | Oct 16, 2024 | 1 | $132K | 4 | Oct 17, 2024 | Director |
APRE | Aprea Therapeutics, Inc. | Oct 14, 2024 | 1 | $490 | 4 | Oct 16, 2024 | Director |
APRE | Aprea Therapeutics, Inc. | Jun 20, 2024 | 2 | $0 | 4 | Jun 21, 2024 | Director |
APRE | Aprea Therapeutics, Inc. | Aug 23, 2023 | 6 | $0 | 4 | Aug 24, 2023 | Director |
APRE | Aprea Therapeutics, Inc. | Jul 28, 2022 | 2 | $0 | 4 | Aug 1, 2022 | Director |
APRE | Aprea Therapeutics, Inc. | May 16, 2022 | 0 | $0 | 3 | May 26, 2022 | Director |